US 7906550
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted A61KA61K31/40A61K45/06
Quick answer
US patent 7906550 (Inhibitors of serine proteases, particularly HCV NS3-NS4A protease) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/40, A61K45/06, A61P, A61P31/12